PCR Amplification on Whole Blood Samples Treated with Different Commonly Used Anticoagulants.
Djordjevic V, Stankovic M, Nikolic A, Antonijevic N, Rakicevic L J, Divac A, Radojkovic M
Purpose
Conclusion
Studies (3)
Purpose
To determine if treatment of whole blood with anticoagulants affects PCR amplification of extracted DNA.
Summary of Findings
PCR amplification of DNA extracted from blood samples were comparable across samples treated with anticoagulants.
Biospecimens
FluidBloodPreservation Types
None (Fresh)Diagnoses
Not specifiedPlatforms
DNAPCRPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Acquisition Anticoagulant Lithium heparinPotassium EDTASodium citrateSodium heparin
Purpose
To determine if anticoagulant treatment affects PCR amplification of whole blood.
Summary of Findings
PCR amplification efficiency using whole blood varied in an anticoagulant dependent manner. The greatest yield was observed with whole blood treated with lithium heparin, while decreased and no amplification were observed with K3EDTA and sodium heparin treatment, respectively.
Biospecimens
FluidBloodPreservation Types
None (Fresh)Diagnoses
Not specifiedPlatforms
DNAPCRPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Acquisition Anticoagulant Lithium heparinPotassium EDTASodium citrateSodium heparin
Purpose
Summary of Findings
Biospecimens
FluidBloodPreservation Types
None (Fresh)Diagnoses
Not specifiedPlatforms
DNAPCRPre-analytical Factors
Classification Pre-Analytical Factor Value(s) PCR Specific Number of cycles 1 cycle3 cycles5 cyclesPCR Specific Template/input amount 1 ul1:1 dilution1:10 dilution1:2 dilution1:5 dilution3 ul5 ul